Fresenius Medical Care AG (Fresenius Medical Care AG) Debt-to-Equity

: 0.89 (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

Fresenius Medical Care AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1,703 Mil. Fresenius Medical Care AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $11,438 Mil. Fresenius Medical Care AG's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $14,853 Mil. Fresenius Medical Care AG's debt to equity for the quarter that ended in Dec. 2023 was 0.88.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Fresenius Medical Care AG's Debt-to-Equity or its related term are showing as below:

FMS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.64 Med: 0.91 Max: 1.15
Current: 0.89

During the past 13 years, the highest Debt-to-Equity Ratio of Fresenius Medical Care AG was 1.15. The lowest was 0.64. And the median was 0.91.

FMS's Debt-to-Equity is ranked worse than
69.85% of 544 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs FMS: 0.89

Fresenius Medical Care AG Debt-to-Equity Historical Data

The historical data trend for Fresenius Medical Care AG's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

1.15

1.10

1.05

0.94

0.89

Fresenius Medical Care AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Debt-to-Equity																0.94	0.96	0.97	0.93	0.89

Competitive Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG Debt-to-Equity Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Debt-to-Equity falls into.

Fresenius Medical Care AG Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Fresenius Medical Care AG's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1702.903	+	11438.222)	/	14853.065
	=	0.88

Fresenius Medical Care AG's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1702.903	+	11438.222)	/	14853.065
	=	0.88

Fresenius Medical Care AG (NYSE:FMS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Fresenius Medical Care AG Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

FMCQF:USA FME:Italy FMEd:UK 0H9X:UK FME:Germany FMEA:Germany FME:Germany FME:Germany FMEA:Germany FME:Germany FMSC34:Brazil FME:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.freseniusmedicalcare.com

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

Executives

Helen Pring Giza

Board of Directors